Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 1: Line 1:
mpo (myeloperoxidase)  
mpo (myeloperoxidase)  


An indicator of granulocytic maturation that in acute leukaemia is highly specificity for the diagnosis of aml. expression should not be observed in typical all but mpo can contribute to a diagnosis of mixed-phenotype acute leukaemia mpal.  note  that although specific for aml expression may not occur on more primitive aml forms or where maturation is non-granulocytic e.g. monocytic erythroid or megakaryocyte lineages   
MPO expression is strongly associated with granulocytic maturation. In acute leukaemia MPO has high specificity for the diagnosis of AML, although expression may be observed on more primitive AML, or where maturation is non-granulocytic e.g. erythroid or megakaryocyte lineages and on some monocytic cases. Expression is not observed in typical ALL, if MPO is detected in ALL then this supports the diagnosis of mixed-phenotype acute leukaemia (MPAL).  


normal function and expression   
normal function and expression   


myeloperoxidase is a lysosomal enzyme that produces hypochlorous acid from hydrogen peroxide during the neutrophil neutrophil respiratory burst these reactive compounds are used by the neutrophil to kill pathogens. mpo is present in neutrophils and eosinophils at all stages of maturation and developing basophils. mpo staining is seen in monocytes but at low intensity. erythroid precursors and lymphocytes are mpo-negative.   
Myeloperoxidase is a lysosomal enzyme used by neutrophils to kill pathogens. It is present in neutrophils and eosinophils at all stages of maturation, and in developing basophils. MPO may be expressed at low intensity in monocytes but erythroid precursors and lymphocytes are MPO-negative.   




what is its diagnostic role   
what is its diagnostic role   
*as a diagnostic antibody in aml expressed in around 60% of aml cases generally those with granulocytic maturation weakly expressed by promonocytes. *in otherwise typical all a small number of mpo-expressing cells is allowed precise criteria vary but generally 5% In cases with mixed phenotype acute leukaemia mpal expression of mpo can alone be used to establish myeloid lineage  
 
*MPO is expressed in around 60% of AML cases - generally those with granulocytic maturation and is weakly expressed by promonocytes
*In otherwise typical ALL a small number of MPO-expressing cells may be seen although precise criteria vary (most often <5%)
*In cases of mixed phenotype acute leukaemia (MPAL), expression of mpo can alone be used to establish myeloid differentiation  


other relevant information   
other relevant information   
technically enzymatic measures of mpo either mpo cytochemistry or sudan black b are probably least sensitive. flow cytometric detection of mpo has lower sensitivy than immunohistochemical detection on trephine this may be because ihc detects expression ofprecursor enzyme form of mpo as well as thefunctional form . if there is doubt about the level of expression then ich on trephine biopsies can be useful.  
Technically enzymatic measures of MPO (cytochemical or sudan black B staining) are probably the least sensitive detection methods. Flow cytometric detection of MPO has lower sensitivy than immunohistochemical detection on trephine; this may be because immunocytochemistry detects expression of a precursor enzyme form of MPO as well as thefunctional form. For this reason, if there is doubt about MPO expression then MPO staining of trephine biopsies can be useful.  


summary tables   
summary tables   

Revision as of 09:42, 31 May 2023

mpo (myeloperoxidase)

MPO expression is strongly associated with granulocytic maturation. In acute leukaemia MPO has high specificity for the diagnosis of AML, although expression may be observed on more primitive AML, or where maturation is non-granulocytic e.g. erythroid or megakaryocyte lineages and on some monocytic cases. Expression is not observed in typical ALL, if MPO is detected in ALL then this supports the diagnosis of mixed-phenotype acute leukaemia (MPAL).

normal function and expression

Myeloperoxidase is a lysosomal enzyme used by neutrophils to kill pathogens. It is present in neutrophils and eosinophils at all stages of maturation, and in developing basophils. MPO may be expressed at low intensity in monocytes but erythroid precursors and lymphocytes are MPO-negative.


what is its diagnostic role

  • MPO is expressed in around 60% of AML cases - generally those with granulocytic maturation and is weakly expressed by promonocytes
  • In otherwise typical ALL a small number of MPO-expressing cells may be seen although precise criteria vary (most often <5%)
  • In cases of mixed phenotype acute leukaemia (MPAL), expression of mpo can alone be used to establish myeloid differentiation

other relevant information Technically enzymatic measures of MPO (cytochemical or sudan black B staining) are probably the least sensitive detection methods. Flow cytometric detection of MPO has lower sensitivy than immunohistochemical detection on trephine; this may be because immunocytochemistry detects expression of a precursor enzyme form of MPO as well as thefunctional form. For this reason, if there is doubt about MPO expression then MPO staining of trephine biopsies can be useful.

summary tables

expression by acute leukaemias and by haematogones rare pro-ball rare early pre-ball rare pre-ball rare ball rare pro-tall rare mature-tall mod aml * rare haemato-gones

  • *inamlmpoishighly specific fordiagnosis butisnotdetected inallcases 2.

expression byb-lymphoproliferative disorders rare cll* rare pll rare mcl rare fl rare hcl rare hclv rare mzl rare lpl rare pcs